PLASMINOGEN MODULATION OF IL-1-STIMULATED DEGRADATION IN BOVINE AND HUMAN ARTICULAR-CARTILAGE EXPLANTS - THE ROLE OF THE ENDOGENOUS INHIBITORS - PAI-1, ALPHA(2)-ANTIPLASMIN, ALPHA(1)-PI, ALPHA(2)-MACROGLOBULINAND TIMP
J. Oleksyszyn et Aj. Augustine, PLASMINOGEN MODULATION OF IL-1-STIMULATED DEGRADATION IN BOVINE AND HUMAN ARTICULAR-CARTILAGE EXPLANTS - THE ROLE OF THE ENDOGENOUS INHIBITORS - PAI-1, ALPHA(2)-ANTIPLASMIN, ALPHA(1)-PI, ALPHA(2)-MACROGLOBULINAND TIMP, Inflammation research, 45(9), 1996, pp. 464-472
The studies described here examine the involvement of the fibrinolytic
cascade and its endogenous inhibitors in the regulation of activity o
f matrix metalloproteinases and cartilage degradation related to non-i
nflammatory joint disease, like osteoarthritis. An interleukin-1-induc
ed model of degradation using [S-35]-labeled bovine and human articula
r cartilage explants was utilized. One goal of these studies was to co
mpare the responses of bovine and human articular cartilage. Degradati
on was not inhibited by alpha(1)-PI, PAI-1, alpha(2)-macroglobulin, al
pha(2)-antiplasmin or TIMP-2, when IL-1 alone was added. Addition of h
uman plasminogen to bovine explants, at concentrations found in human
synovial fluid, increased degradation by three to four-fold. Under the
se conditions, the degradation was inhibited effectively by all of the
endogenous inhibitors tested, indicating the presence of a cascade wh
ere activated chondrocytes are a source of u-PA. Plasminogen activated
by u-PA gives plasmin, which is known to further activate pro-stromel
ysin. Stromelysin is essential for activation of collegenase. Not only
TIMP, but also inhibitors at earlier steps of activation like PAI-1,
alpha(2)-antiplasmin, alpha(1)-PI and alpha(2)-macroglobulin inhibited
degradation, and could provide cartilage protection in vivo. An exper
iment with human articular cartilage explants showed that very little
or no degradation occurred when human articular cartilage explants wer
e stimulated with interleukin-1 alone. Addition of human plasminogen (
at physiologically relevant concentrations) resulted in significant de
gradation, which was inhibited in the same manner as in bovine explant
s, by inhibitors of the fibrinolytic cascade and TIMP. TIMP is much mo
re efficient in human explants, indicating the limited participation o
f human plasmin in the degradation of human cartilage. Although specul
ative, it is possible that in vivo, cartilage degradation could be pro
moted not only by TIMP/MMP imbalance, but also accelerated by decrease
d levels of certain serpins in synovial fluid (e.g. PAIs, alpha(2)-ant
iplasmin and alpha(1)-PI).